Clinical Trials Directory

Trials / Completed

CompletedNCT00080184

Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia

Effectiveness of EEG Biofeedback in the Treatment of Fibromyalgia

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
40 (planned)
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.

Detailed description

Fibromyalgia (FM) is a chronic disorder that involves chronic widespread musculoskeletal pain typically accompanied by fatigue, disordered sleep, cognitive complaints, psychological distress, and impairments in functioning. Treatments to date have been only partially effective and typically of modest benefit. Many persons with FM remain persistently dysfunctional and often disabled. This has given greater impetus for patients to seek complementary and alternative medicine (CAM) therapies. In this study, a variant of electroencephalograph (EEG) biofeedback known as Low Energy Neurofeedback System (LENS) will be used to reduce FM symptoms. Participants in this study will be randomly assigned to receive either LENS or placebo for several sessions. The Fibromyalgia Impact Questionnaire will be used to assess participants at the end of the study and at the 3- and 6- month follow-up visits.

Conditions

Interventions

TypeNameDescription
PROCEDURELow Energy Neurofeedback System

Timeline

Start date
2003-12-01
Completion
2006-05-01
First posted
2004-03-25
Last updated
2006-08-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00080184. Inclusion in this directory is not an endorsement.